Výsledky vyhledávání - "Rose Beamish"

Immobilized FhuD2 Siderophore-Binding Protein Enables Purification of Salmycin Sideromycins from Streptomyces violaceus DSM 8286

Autor: Catherine Rose Beamish, Gerry Sann M. Rivera, Timothy A. Wencewicz

Publikováno v: ACS infectious diseases. 4(5)

Siderophores are a structurally diverse class of natural products common to most bacteria and fungi as iron(III)-chelating ligands. Siderophores, including trihydroxamate ferrioxamines, are used clinically to treat iron overload diseases and show pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749a4572327eabce4b9bb06c7f09cc59
https://pubmed.ncbi.nlm.nih.gov/29460625

Zobrazit plný text záznamu

PO145 ICORG 13-01 ABC SURVEY: ARE WE MEETING THE NEEDS OF PATIENTS WITH ADVANCED BREAST CANCER (ABC) IN IRELAND? A NATIONWIDE SURVEY

Autor: Algirdas Stockunas, Linda Coate, Hennessey Brian, Miriam O'Connor, Maccon M. Keane, Catherine M. Kelly, Seamus O'Reilly, John P. Crowne, Jeffri R. M. Ismail, Jodie E. Battley, Janice M. Walshe, Rose Beamish, M. John Kennedy, Conleth G. Murphy, Brian Richard Bird, Verena Murphy, Deirdre O'Mahony, K Duffy, Michael J. Martin

Publikováno v: The Breast. 24:S71-S72

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a238adeb2c105f47ac4638e74521bb00
https://doi.org/10.1016/s0960-9776(15)30157-0

Zobrazit plný text záznamu

A comparative analysis of distant recurrence risk assessments by Oncotype DX recurrence score alone and integrated with clinicopathologic factors in early-stage breast cancer

Autor: Seamus O'Reilly, Sharon F. McGee, Jennifer K. Litton, Ciara Marie Kelly, Martina Smith, Lajos Pusztai, John Crown, John McCaffrey, Miriam O'Connor, Eugene J. Moylan, Catherine M. Kelly, Ana M. Gonzalez-Angulo, Rose Beamish

Publikováno v: Journal of Clinical Oncology. 31:598-598

598 Background: Treatment planning for patients with node negative, ER-positive, HER-2 negative breast cancer often incorporates the use of prognostic and predictive tools like Oncotype DX. Prior to the availabilty of Oncotype DX, clinicopathologic f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cf436d00557e5d2b2ee43919888c93f4
https://doi.org/10.1200/jco.2013.31.15_suppl.598

Zobrazit plný text záznamu

Does Oncotype DX recurrence score correlate with survival benefit in 'good prognosis' patients as estimated by AdjuvantOnline!?

Autor: Rose Beamish, Min Yuen Teo, Seamus O'Reilly, Louise C. Connell, Eugene J. Moylan

Publikováno v: Journal of Clinical Oncology. 29:38-38

38 Background: An important question for ER positive, node negative breast cancer is the benefit of chemotherapy over hormonal therapy. We sought to explore if a low estimate of chemotherapy benefit, based on AdjuvantOnline, correlated with low risk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4087b6451d6d0f8a6bd81859a1cdbbb
https://doi.org/10.1200/jco.2011.29.27_suppl.38

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání